Englewood, CO, United States
Dr. Koetting is an Assistant Professor at the University of Colorado School of Medicine in the Department of Ophthalmology in Denver, CO. Her primary focus is in anterior segment and ocular surface disease, neuro-optometry, and peri-operative care. She partakes in clinical research and has served Externship Director and adjunct faculty for several schools and colleges of optometry.
Dr. Koetting is a member of Intrepid, a fellow in the American Academy of Optometry, a diplomate of the American Board of Optometry, an active member of AOA and has served as both local and state officers within AOA. She was named young Optometrist of the year by the state of Virginia. Dr. Koetting lectures locally, nationally and internationally at conferences, continually contributes articles to and serves on editorial board for multiple publications.
101 - Floaters in Focus: Assessing Treatment of Vitreous Opacities
Thursday, February 26, 2026
7:00 AM - 8:00 AM EDT
Disclosure(s): AbbVie/Allergan: Consulting Fees (); Alcon: Consulting Fees (), Speaker's Bureau (honoraria or other compensation) (); Aldeyra Therapeutics: Consulting Fees (); Azura Ophthalmics: Consulting Fees (); Bausch + Lomb: Consulting Fees (), Independent Contractor (including contracted research) (), Speaker's Bureau (honoraria or other compensation) (); Blephex: Consulting Fees (); Blinkjoy: Consulting Fees (); Brill: Consulting Fees (); Bruder: Consulting Fees (); Dompe: Consulting Fees (), Speaker's Bureau (honoraria or other compensation) (); Glaukos: Consulting Fees (); Harrow: Speaker's Bureau (honoraria or other compensation) (); Iveric Bio: Consulting Fees (); KALA Pharmaceuticals: Researcher (grant funding or other support) (); MOVU: Advisory Committee/Board Member (), Consulting Fees (), Consulting Fees (); Myze: Consulting Fees (); NuLids: Consulting Fees (); Orasis: Consulting Fees (), Researcher (grant funding or other support) (), Speaker's Bureau (honoraria or other compensation) (); PRN/EyePromise: Consulting Fees (), Speaker's Bureau (honoraria or other compensation) (); Science Based Health: Consulting Fees (); Scope: Consulting Fees (); Sight Sciences: Consulting Fees (); Tarsus Pharma: Consulting Fees (), Researcher (grant funding or other support) (), Speaker's Bureau (honoraria or other compensation) (); Tenpoint: Consulting Fees (); Thea Pharma: Consulting Fees (), Researcher (grant funding or other support) (); Topcon: Consulting Fees (); Trukera (B+L): Consulting Fees (); Viatris: Speaker's Bureau (honoraria or other compensation) (); Vital Tears: Consulting Fees ()
504 - Nutrition and The Eye From Front to Back
Thursday, February 26, 2026
6:45 PM - 7:45 PM EDT
Disclosure(s): AbbVie/Allergan: Consulting Fees (); Alcon: Consulting Fees (), Speaker's Bureau (honoraria or other compensation) (); Aldeyra Therapeutics: Consulting Fees (); Azura Ophthalmics: Consulting Fees (); Bausch + Lomb: Consulting Fees (), Independent Contractor (including contracted research) (), Speaker's Bureau (honoraria or other compensation) (); Blephex: Consulting Fees (); Blinkjoy: Consulting Fees (); Brill: Consulting Fees (); Bruder: Consulting Fees (); Dompe: Consulting Fees (), Speaker's Bureau (honoraria or other compensation) (); Glaukos: Consulting Fees (); Harrow: Speaker's Bureau (honoraria or other compensation) (); Iveric Bio: Consulting Fees (); KALA Pharmaceuticals: Researcher (grant funding or other support) (); MOVU: Advisory Committee/Board Member (), Consulting Fees (), Consulting Fees (); Myze: Consulting Fees (); NuLids: Consulting Fees (); Orasis: Consulting Fees (), Researcher (grant funding or other support) (), Speaker's Bureau (honoraria or other compensation) (); PRN/EyePromise: Consulting Fees (), Speaker's Bureau (honoraria or other compensation) (); Science Based Health: Consulting Fees (); Scope: Consulting Fees (); Sight Sciences: Consulting Fees (); Tarsus Pharma: Consulting Fees (), Researcher (grant funding or other support) (), Speaker's Bureau (honoraria or other compensation) (); Tenpoint: Consulting Fees (); Thea Pharma: Consulting Fees (), Researcher (grant funding or other support) (); Topcon: Consulting Fees (); Trukera (B+L): Consulting Fees (); Viatris: Speaker's Bureau (honoraria or other compensation) (); Vital Tears: Consulting Fees ()
62 - Special Session - The Tried, The True, & The New in Ocular Surface Disease
Friday, February 27, 2026
9:00 AM - 11:00 AM EDT
Disclosure(s): AbbVie/Allergan: Consulting Fees (); Alcon: Consulting Fees (), Speaker's Bureau (honoraria or other compensation) (); Aldeyra Therapeutics: Consulting Fees (); Azura Ophthalmics: Consulting Fees (); Bausch + Lomb: Consulting Fees (), Independent Contractor (including contracted research) (), Speaker's Bureau (honoraria or other compensation) (); Blephex: Consulting Fees (); Blinkjoy: Consulting Fees (); Brill: Consulting Fees (); Bruder: Consulting Fees (); Dompe: Consulting Fees (), Speaker's Bureau (honoraria or other compensation) (); Glaukos: Consulting Fees (); Harrow: Speaker's Bureau (honoraria or other compensation) (); Iveric Bio: Consulting Fees (); KALA Pharmaceuticals: Researcher (grant funding or other support) (); MOVU: Advisory Committee/Board Member (), Consulting Fees (), Consulting Fees (); Myze: Consulting Fees (); NuLids: Consulting Fees (); Orasis: Consulting Fees (), Researcher (grant funding or other support) (), Speaker's Bureau (honoraria or other compensation) (); PRN/EyePromise: Consulting Fees (), Speaker's Bureau (honoraria or other compensation) (); Science Based Health: Consulting Fees (); Scope: Consulting Fees (); Sight Sciences: Consulting Fees (); Tarsus Pharma: Consulting Fees (), Researcher (grant funding or other support) (), Speaker's Bureau (honoraria or other compensation) (); Tenpoint: Consulting Fees (); Thea Pharma: Consulting Fees (), Researcher (grant funding or other support) (); Topcon: Consulting Fees (); Trukera (B+L): Consulting Fees (); Viatris: Speaker's Bureau (honoraria or other compensation) (); Vital Tears: Consulting Fees ()
113 - Made to Order: Custom Meds for the Cornea and Ocular Surface
Friday, February 27, 2026
12:00 PM - 1:00 PM EDT
Disclosure(s): AbbVie/Allergan: Consulting Fees (); Alcon: Consulting Fees (), Speaker's Bureau (honoraria or other compensation) (); Aldeyra Therapeutics: Consulting Fees (); Azura Ophthalmics: Consulting Fees (); Bausch + Lomb: Consulting Fees (), Independent Contractor (including contracted research) (), Speaker's Bureau (honoraria or other compensation) (); Blephex: Consulting Fees (); Blinkjoy: Consulting Fees (); Brill: Consulting Fees (); Bruder: Consulting Fees (); Dompe: Consulting Fees (), Speaker's Bureau (honoraria or other compensation) (); Glaukos: Consulting Fees (); Harrow: Speaker's Bureau (honoraria or other compensation) (); Iveric Bio: Consulting Fees (); KALA Pharmaceuticals: Researcher (grant funding or other support) (); MOVU: Advisory Committee/Board Member (), Consulting Fees (), Consulting Fees (); Myze: Consulting Fees (); NuLids: Consulting Fees (); Orasis: Consulting Fees (), Researcher (grant funding or other support) (), Speaker's Bureau (honoraria or other compensation) (); PRN/EyePromise: Consulting Fees (), Speaker's Bureau (honoraria or other compensation) (); Science Based Health: Consulting Fees (); Scope: Consulting Fees (); Sight Sciences: Consulting Fees (); Tarsus Pharma: Consulting Fees (), Researcher (grant funding or other support) (), Speaker's Bureau (honoraria or other compensation) (); Tenpoint: Consulting Fees (); Thea Pharma: Consulting Fees (), Researcher (grant funding or other support) (); Topcon: Consulting Fees (); Trukera (B+L): Consulting Fees (); Viatris: Speaker's Bureau (honoraria or other compensation) (); Vital Tears: Consulting Fees ()